BioSpace News Archive

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its Board of Directors has approved the planned transition of Chairman, President and Chief Executive Officer Jeffrey Leiden, M.D., Ph.D, into the role of Executive Chairman of the Board, effective April 1, 2020.

Myomo®, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, was recently a featured presenter at the United Brachial Plexus Network’s Camp UBPN, a worldwide initiative striving to inform and unite patients affected by brachial plexus injuries.

Stimwave Technologies is the leading innovator of wireless medical pain relief implant bioelectric technology.

President’s Symposium Examines the Important Role of the Public, Private, and Philanthropic Sectors to Make Oral Health Care More Accessible

Mr. O’Neill brings with him more than twenty-years experience in the agricultural and food industries, including sales, business development, market research, and various management roles.

CAPTIVATE clinical trial initiated and enrollment progressing

Proceeds will be used to advance the company’s novel CZ-02 program, which targets multi-drug resistant (MDR) gram-negative infections.

An archived replay of the webcast will be available for approximately 30 days following the presentation.

Stapley is President and CEO of genomics company Helix and a member of the Glaukos Board of Directors.

The Natural Medicines FDA Advisory tool identifies commercial products containing ingredients flagged by the FDA, and provides resources on safety and use to help mitigate risks to patients.